Literature DB >> 10938130

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.

A Melnick1, K F Ahmad, S Arai, A Polinger, H Ball, K L Borden, G W Carlile, G G Prive, J D Licht.   

Abstract

The promyelocytic leukemia zinc finger (PLZF) protein is a transcription factor disrupted in patients with t(11;17)(q23;q21)-associated acute promyelocytic leukemia. PLZF contains an N-terminal BTB/POZ domain which is required for dimerization, transcriptional repression, formation of high-molecular-weight DNA-protein complexes, nuclear sublocalization, and growth suppression. X-ray crystallographic data show that the PLZF BTB/POZ domain forms an obligate homodimer via an extensive interface. In addition, the dimer possesses several highly conserved features, including a charged pocket, a hydrophobic monomer core, an exposed hydrophobic surface on the floor of the dimer, and two negatively charged surface patches. To determine the role of these structures, mutational analysis of the BTB/POZ domain was performed. We found that point mutations in conserved residues that disrupt the dimer interface or the monomer core result in a misfolded nonfunctional protein. Mutation of key residues from the exposed hydrophobic surface suggests that these are also important for the stability of PLZF complexes. The integrity of the charged-pocket region was crucial for proper folding of the BTB/POZ domain. In addition, the pocket was critical for the ability of the BTB/POZ domain to repress transcription. Alteration of charged-pocket residue arginine 49 to a glutamine (mutant R49Q) yields a domain that can still dimerize but activates rather than represses transcription. In the context of full-length PLZF, a properly folded BTB/POZ domain was required for all PLZF functions. However, PLZF with the single pocket mutation R49Q repressed transcription, while the double mutant D35N/R49Q could not, despite its ability to dimerize. These results indicate that PLZF requires the BTB/POZ domain for dimerization and the charged pocket for transcriptional repression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10938130      PMCID: PMC86130          DOI: 10.1128/MCB.20.17.6550-6567.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

Review 1.  Chromatin remodeling and leukemia: new therapeutic paradigms.

Authors:  R L Redner; J Wang; J M Liu
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

Review 2.  Deconstructing a disease: RARalpha, its fusion partners, and their roles in the pathogenesis of acute promyelocytic leukemia.

Authors:  A Melnick; J D Licht
Journal:  Blood       Date:  1999-05-15       Impact factor: 22.113

Review 3.  Chromatin-modifying and -remodeling complexes.

Authors:  R D Kornberg; Y Lorch
Journal:  Curr Opin Genet Dev       Date:  1999-04       Impact factor: 5.578

4.  The N-terminal POZ domain of GAGA mediates the formation of oligomers that bind DNA with high affinity and specificity.

Authors:  M L Espinás; E Jiménez-García; A Vaquero; S Canudas; J Bernués; F Azorín
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

5.  Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein.

Authors:  J Y Li; M A English; H J Ball; P L Yeyati; S Waxman; J D Licht
Journal:  J Biol Chem       Date:  1997-09-05       Impact factor: 5.157

6.  The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.

Authors:  K D Huynh; V J Bardwell
Journal:  Oncogene       Date:  1998-11-12       Impact factor: 9.867

7.  Co-operative DNA binding by GAGA transcription factor requires the conserved BTB/POZ domain and reorganizes promoter topology.

Authors:  K R Katsani; M A Hajibagheri; C P Verrijzer
Journal:  EMBO J       Date:  1999-02-01       Impact factor: 11.598

8.  Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B.

Authors:  S Deltour; C Guerardel; D Leprince
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

9.  Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.

Authors:  X Li; H Peng; D C Schultz; J M Lopez-Guisa; F J Rauscher; R Marmorstein
Journal:  Cancer Res       Date:  1999-10-15       Impact factor: 12.701

10.  Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.

Authors:  P L Yeyati; R Shaknovich; S Boterashvili; J Li; H J Ball; S Waxman; K Nason-Burchenal; E Dmitrovsky; A Zelent; J D Licht
Journal:  Oncogene       Date:  1999-01-28       Impact factor: 9.867

View more
  56 in total

1.  The SCAN domain of ZNF174 is a dimer.

Authors:  James R Stone; Jenny L Maki; Stephen C Blacklow; Tucker Collins
Journal:  J Biol Chem       Date:  2001-12-11       Impact factor: 5.157

Review 2.  All in the family: the BTB/POZ, KRAB, and SCAN domains.

Authors:  T Collins; J R Stone; A J Williams
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

3.  Phyllopod acts as an adaptor protein to link the sina ubiquitin ligase to the substrate protein tramtrack.

Authors:  Songhui Li; Chunyan Xu; Richard W Carthew
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

Review 4.  POK/ZBTB proteins: an emerging family of proteins that regulate lymphoid development and function.

Authors:  Sung-Uk Lee; Takahiro Maeda
Journal:  Immunol Rev       Date:  2012-05       Impact factor: 12.988

5.  ZENON, a novel POZ Kruppel-like DNA binding protein associated with differentiation and/or survival of late postmitotic neurons.

Authors:  Hélène Kiefer; Fabienne Chatail-Hermitte; Philippe Ravassard; Elisa Bayard; Isabelle Brunet; Jacques Mallet
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

6.  A family of human zinc finger proteins that bind methylated DNA and repress transcription.

Authors:  Guillaume J P Filion; Svetlana Zhenilo; Sergey Salozhin; Daisuke Yamada; Egor Prokhortchouk; Pierre-Antoine Defossez
Journal:  Mol Cell Biol       Date:  2006-01       Impact factor: 4.272

7.  Up-regulation of hyperpolarization-activated cyclic nucleotide-gated channel 3 (HCN3) by specific interaction with K+ channel tetramerization domain-containing protein 3 (KCTD3).

Authors:  Xiaochun Cao-Ehlker; Xiangang Zong; Verena Hammelmann; Christian Gruner; Stefanie Fenske; Stylianos Michalakis; Christian Wahl-Schott; Martin Biel
Journal:  J Biol Chem       Date:  2013-02-04       Impact factor: 5.157

8.  Regulation of the cyclin-dependent kinase inhibitor 1A gene (CDKN1A) by the repressor BOZF1 through inhibition of p53 acetylation and transcription factor Sp1 binding.

Authors:  Min-Kyeong Kim; Bu-Nam Jeon; Dong-In Koh; Kyung-Sup Kim; So-Yoon Park; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

9.  Ectromelia virus encodes a BTB/kelch protein, EVM150, that inhibits NF-κB signaling.

Authors:  Qian Wang; Kristin Burles; Brianne Couturier; Crystal M H Randall; Joanna Shisler; Michele Barry
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

10.  rosy Function is required for juvenile hormone effects in Drosophila melanogaster.

Authors:  Xiaofeng Zhou; Lynn M Riddiford
Journal:  Genetics       Date:  2008-01       Impact factor: 4.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.